Cargando…
Administration of Monoclonal Antibody for COVID-19 in Patient Homes
This cohort study examines the outcomes of a program providing monoclonal antibody treatments to COVID-19–positive patients in their homes.
Autores principales: | Malani, Anurag N., LaVasseur, Beth, Fair, Jason, Domeier, Robert, Vershum, Rita, Fowler, Robin, Collins, Curtis D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Medical Association
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8517740/ https://www.ncbi.nlm.nih.gov/pubmed/34648014 http://dx.doi.org/10.1001/jamanetworkopen.2021.29388 |
Ejemplares similares
-
Re: Hormonal therapies and venous thrombosis: The estrogen matters! Morimont et al.
por: LaVasseur, Corinne, et al.
Publicado: (2023) -
Pregnancy outcomes after administration of monoclonal antibody therapy for COVID-19
por: Martinez-Baladejo, Maria T., et al.
Publicado: (2023) -
Administration of Anti–SARS-CoV-2 Monoclonal Antibodies After US Food and Drug Administration Deauthorization
por: Anderson, Timothy S., et al.
Publicado: (2022) -
Doctors' Fees and Nursing Homes
por: Game, Fair
Publicado: (1912) -
Monoclonal Antibody Use in Post-Acute and Long-Term Care: A Call to Action
por: Palat, Sing T., et al.
Publicado: (2021)